Apparatus and method for self-induced cough cardiopulmonary resuscitation
AssigneePneumoflex Systems, LLC
InventorsW Robert Addington, Robert E Stephens, Stuart P Miller
Life of this patent
Estimating the term…
Loading patent…
AssigneePneumoflex Systems, LLC
InventorsW Robert Addington, Robert E Stephens, Stuart P Miller
Estimating the term…
A apparatus and method for self-treatment of cardiac arrhythmia by a patient, comprising a container sized to be portable by the patient and having therein a chamber containing a medicament composition comprising a pharmaceutically acceptable carrier mixed with a chemoirritant, preferably L-tartaric acid; a nebulizing valve connected to the chamber so as to provide an outlet therefor, a source of motivating force connected with the chamber so as to motivate the composition through the opening in the nebulizing valve to thereby cause nebulization of the composition; a wireless transmitter responsive to activation of the nebulizer for sending a wireless signal requesting medical assistance; and a power source operatively connected for providing power; wherein the chemoirritant is mixed in the composition in an amount sufficient for causing the patient to produce an involuntary cough effective to maintain at least partial blood circulation.
A nebulizer apparatus for self-treatment of cardiac arrhythmia by production of an involuntary cough in a patient, comprising:
A nebulizer apparatus for self-treatment by a patient, comprising:
A treatment kit for self-treatment of cardiac arrhythmia by a patient, said kit comprising:
A method for treatment of cardiac arrhythmia, comprising nebulizing into the respiratory tract of a patient a medicament composition comprising a pharmaceutically acceptable carrier mixed with a chemoirritant effective for producing an involuntary cough in the patient sufficient to maintain at least partial blood circulation.
An L-tartaric acid composition for therapeutic use as a medicament in a patient having cardiac arrhythmia, the composition comprising a pharmaceutically acceptable carrier mixed with an effective amount of L-tartaric acid for causing production by the patient of an involuntary cough effective to maintain at least partial blood circulation during the cardiac arrhythmia.
Dependencies are inferred from the claim text.